Fangzhou Inc. (HKG:6086)

Market Cap	3.82B
Revenue (ttm)	3.15B +16.7%
Net Income	-25.95M
EPS	-0.02
Shares Out	1.34B
PE Ratio	n/a
Forward PE	126.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,483,000
Average Volume	44,605,553
Open	2.830
Previous Close	2.850
Day's Range	2.810 - 3.020
52-Week Range	2.090 - 7.550
Beta	n/a
RSI	50.53
Earnings Date	Mar 20, 2026

About Fangzhou

Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content And Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It also provides H2H services, including online medical consultation services, e-prescription, and prescriptio...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2015
• Employees: 485
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6086

Financial Performance

In 2024, Fangzhou's revenue was 2.71 billion, an increase of 11.22% compared to the previous year's 2.43 billion. Losses were -854.89 million, 334.4% more than in 2023.

Financial numbers in CNY